Focal interstitial irradiation is being used in the clinical management of malignant brain tumors and generally follows a conventional teletherapy protocol. This approach is effective against certain types of tumors, but has the potential for causing substantial damage to normal brain tissues. An alternative approach is to use focal high-dose external-beam irradiation, i.e., radiosurgery, instead of high activity radioisotopes. However, the deleterious effects of radiosurgery have not been well studied, and critical biological information is lacking, particularly regarding dose-volume relationships, and the extent to which focal radiation-induced injury can be modified. This proposal focuses on three hypotheses related to the response of normal brain tissue to high-dose focal irradiation: 1) the severity of radiation-induced damage is related to the volume of irradiated tissue; 2) subtle changes in morphology/physiology can predict the ultimate tissue breakdown caused by radiosurgery; and, 3) the pathophysiologic consequences of radiosurgery are mediated in part by the presence of polyamines, and reductions in tissue polyamine levels may moderate the extent of radiation-induced injury. The proposed study will involve a dog model and will use well- established noninvasive methodologies to measure volumes of injury, vascular permeability (blood-to-brain, k/i, and brain-to-blood, k/b, transfer constants), regional cerebral blood flow (rCBF), mean transit time (MTT) of blood and vascular volume. Immunohistochemical methods will be used for a qualitative and quantitative appraisal of the cellular response in irradiated brain.
The specific aims are: 1) to determine the morphologic and physiologic responses of normal brain as a function of time after a single radiosurgical treatment to a defined volume of normal brain; 2) using multiple quantitative endpoints, to determine the dose response characteristics of normal brain after a single radiosurgical treatment, and quantify how the extent of injury after a specified dose relates to the volume of brain irradiated; 3) in terms of radiation- induced necrosis, to determine if and to what extend dose heterogeneity in the high dose region of the dose distribution affects the dose-volume relationship; 4) to determine if changes in CSF polyamine levels and/or brain tissue density (CT number), blood flow-related parameters (rCBF, MTT, vascular volume), or permeability (k/i and k/b) precede general tissue breakdown and may be useful predictors of the ultimate expression of radiation injury; 5) using immunohistochemical markers specific for macrophages, vascular endothelial cells, astrocytes and cells synthesizing DNA, to qualitatively and quantitatively determine the cellular response of normal brain tissue to focal irradiation; and 6) to determine if and to what extent an intravenous infusion of alpha-difluoromethylornithine (DFMO) modifies the morphologic and physiologic consequences of a standard radiosurgical treatment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA013525-22
Application #
3748806
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
22
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Rodriguez, Fausto J; Tihan, Tarik; Lin, Doris et al. (2014) Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients. Am J Surg Pathol 38:1058-70
Chang, Susan M; Parney, Ian F; Huang, Wei et al. (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557-64
Parney, Ian F; Kunwar, Sandeep; McDermott, Michael et al. (2005) Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma. J Neurosurg 102:267-75
Prados, Michael D; Seiferheld, Wendy; Sandler, Howard M et al. (2004) Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Int J Radiat Oncol Biol Phys 58:1147-52
Levin, Victor A; Hess, Kenneth R; Choucair, Ali et al. (2003) Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Clin Cancer Res 9:981-90
McKnight, Tracy R; von dem Bussche, Mary H; Vigneron, Daniel B et al. (2002) Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97:794-802
Hamel, W; Zirkel, D; Mehdorn, H M et al. (2001) (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells. Cancer Gene Ther 8:388-96
Simmons, M L; Lamborn, K R; Takahashi, M et al. (2001) Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Cancer Res 61:1122-8
Hamel, W; Dazin, P; Israel, M A (1996) Adaptation of a simple flow cytometric assay to identify different stages during apoptosis. Cytometry 25:173-81
Hamel, W; Magnelli, L; Chiarugi, V P et al. (1996) Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells. Cancer Res 56:2697-702

Showing the most recent 10 out of 14 publications